VICTORIA, British Columbia (AP) _ Aurinia Pharmaceuticals Inc. (AUPH) on Monday reported a loss of $51.9 million in its first quarter.
On a per-share basis, the Victoria, British Columbia-based company said it had a loss of 92 cents. Losses, adjusted for non-recurring costs, came to 20 cents per share.
The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 11 cents per share.
The biotechnology company posted revenue of $31,000 in the period, which also did not meet Street forecasts. Four analysts surveyed by Zacks expected $50,000.
Aurinia shares have more than tripled since the beginning of the year. The stock has more than tripled in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AUPH at https://www.zacks.com/ap/AUPH
Keywords: Aurinia Pharmaceuticals, Earnings Report